Buprenorphine: beyond methadone?

This month's guest authors are affiliated with the substance abuse treatment and treatment research unit of the Connecticut Mental Health Center and the department of psychiatry at Yale University School of Medicine, where Dr. Rosen is instructor and Dr. Kosten is associate professor. They disc...

Full description

Saved in:
Bibliographic Details
Published inHospital & community psychiatry Vol. 42; no. 4; p. 347
Main Authors Rosen, M I, Kosten, T R
Format Journal Article
LanguageEnglish
Published United States 01.04.1991
Subjects
Acquired Immunodeficiency Syndrome - prevention & control
Acquired Immunodeficiency Syndrome - transmission
Buprenorphine - therapeutic use
Cocaine
Humans
Methadone - therapeutic use
Opioid-Related Disorders - rehabilitation
Risk Factors
Substance Abuse, Intravenous - rehabilitation
Substance-Related Disorders - rehabilitation
Online AccessGet more information

Cover

More Information
Summary:This month's guest authors are affiliated with the substance abuse treatment and treatment research unit of the Connecticut Mental Health Center and the department of psychiatry at Yale University School of Medicine, where Dr. Rosen is instructor and Dr. Kosten is associate professor. They discuss a promising new treatment that may reduce abuse of cocaine by drug addicts who use intravenous heroin and may indirectly reduce risk-taking behavior associated with transmission of the human immunodeficiency virus.
ISSN:0022-1597
DOI:10.1176/ps.42.4.347